Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

Clinical Microbiology and Infection

Volumn 15, Issue 1, 2009, Pages 60-66

  Islam, S ^a   Oh, H ^a   Jalal, S ^a   Karpati, F ^b   Ciofu, O ^c   Hoiby N ^d   Wretlind, Bengt ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

16S rRNA; Aminoglycoside; Cystic fibrosis; Efflux pump; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BACTERIAL PROTEIN; MESSENGER RNA; PROTEIN MEXY; PROTEIN MEXZ; PROTEIN NUOG; PROTEIN PA5471; RIBOSOMAL PROTEIN L25; RIBOSOME PROTEIN; RNA 16S; TOBRAMYCIN; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA SEQUENCE; GENE EXPRESSION; GENE INACTIVATION; GENE SEQUENCE; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RNA PURIFICATION; SEQUENCE ANALYSIS;

PSEUDOMONAS AERUGINOSA;

EID: 59349093827     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02097.x     Document Type: Article

References (25)

1. Hurley JC, Miller GH, Smith AL. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Diagn Microbiol Infect Dis 1995; 22: 331-336.
2. MacLeod DL, Nelson LE, Shawar RM et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis 2000; 181: 1180-1184.
3. Matsuo Y, Eda S, Gotoh N, Yoshihara E, Nakae T. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett 2004; 238: 23-28.
4. Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2004; 48: 1676-1680.
5. Westbrock-Wadman S, Sherman DR, Hickey MJ et al. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother 1999; 43: 2975-2983.
6. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 2004; 10: 12-26.
7. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plesiat P. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 2007; 51: 1016-1021.
8. Li XZ, Poole K, Nikaido H. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother 2003; 47: 27-33.
9. Aeschlimann JR. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2003; 23: 916-924.
10. Islam S, Jalal S, Wretlind B. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2004; 10: 877-883.
11. Høiby N. Antibiotic therapy for chronic infection of pseudomonas in the lung. Annu Rev Med 1993; 44: 1-10.
12. Jalal S, Ciofu O, Høiby N, Gotoh N, Wretlind B. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2000; 44: 710-712.
13. Oh H, Stenhoff J, Jalal S, Wretlind B. Role of efflux pumps and mutations in genes for topoisomerases. II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 2003; 9: 323-328.
14. Lambert PA. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 2002; 95(suppl 41): 22-26.
15. Saiman L, Mehar F, Niu WW et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996; 23: 532-537.
16. Aires JR, Köhler T, Nikaido H, Plésiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 1999; 43: 2624-2628.
17. Aramaki H, Yagi N, Suzuki M. Residues important for the function of a multihelical DNA binding domain in the new transcription factor family of Cam and Tet repressors. Protein Eng 1995; 8: 1259-1266.
18. Smith EE, Buckley DG, Wu Z et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006; 103: 8487-8492.
19. Morita Y, Sobel ML, Poole K. Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: Involvement of the antibiotic-inducible PA5471 gene product. J Bacteriol 2006; 188: 1847-1855.
20. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 1993; 57: 138-163.
21. Miller GH, Sabatelli FJ, Hare RS et al. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area: A reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups Clin Infect Dis 1997; 24(suppl 1): S46-S62.
22. Recht MI, Douthwaite S, Dahlquist KD, Puglisi JD. Effect of mutations in the A site of 16 S rRNA on aminoglycoside antibiotic-ribosome interaction. J Mol Biol 1999; 286: 33-43.
23. Pfister P, Hobbie S, Vicens Q, Bottger EC, Westhof E. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. Chembiochem 2003; 4: 1078-1088.
24. Prammananan T, Sander P, Brown BA et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis 1998; 177: 1573-1581.
25. Torres C, Perlin MH, Baquero F, Lerner DL, Lerner SA. High-level amikacin resistance in Pseudomonas aeruginosa associated with a 3′-phosphotransferase with high affinity for amikacin. Int J Antimicrob Agents 2000; 15: 257-263.